Profile
Assaf Oron is Chief Executive Officer & Director at Evofuel Ltd. since 2012.
Former roles include Chief Business Officer at BiomX, Inc. from 2019 to 2024, Chief Business Officer at BiomX Ltd. from 2017 to 2019, Executive VP-Corporate Development at Evogene Ltd. from 2013 to 2017, Chief Executive Officer at Chondrocyte Ltd. from 2004 to 2006, and Senior Project Manager at POC Management Consulting from 1999 to 2003.
Education includes undergraduate and graduate degrees from Tel-Aviv University.
Assaf Oron active positions
| Companies | Position | Start |
|---|---|---|
Evofuel Ltd. | Chief Executive Officer | 2011-12-31 |
Former positions of Assaf Oron
| Companies | Position | End |
|---|---|---|
| BIOMX INC. | Corporate Officer/Principal | 2024-10-31 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer treatment | Corporate Officer/Principal | 2019-09-30 |
| EVOGENE LTD. | Corporate Officer/Principal | 2016-12-31 |
Chondrocyte Ltd. | Chief Executive Officer | 2005-12-31 |
POC Management Consulting | Corporate Officer/Principal | 2002-12-31 |
Training of Assaf Oron
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evogene Ltd.
Evogene Ltd. BiotechnologyHealth Technology Operates as computational biology company, which focuses on product discovery and development | Health Technology |
POC Management Consulting | Commercial Services |
Evofuel Ltd. | |
Chondrocyte Ltd. | |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer treatment | Health Technology |
BiomX, Inc.
BiomX, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company developing natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin | Health Technology |
- Stock Market
- Insiders
- Assaf Oron
















